Ixmyelocel-T, mesenchymal stem cells and monocytes for dilated cardiomyopathy
Ixmyelocel-T is a mixture of a CD90+ mesenchymal stem cells and monocytes, specifically expanded by an automated cell-processing system from autologous bone marrow. Other cell types from the bone marrow are partially depleted. Treated cardiomyopathy patients benefit from increased septal thickening and effect on the stratum resulting in better patient outcome.
Read More
Product Information for
Ixmyelocel-T, mesenchymal stem cells and monocytes for dilated cardiomyopathy
Links related to the product - may include a range of information sources (e.g., press releases, websites, patents) related to the specific cell therapy application.
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access